Business · 15/08/2022
FDA Solicits Public Comment on Abbreviated New Drug Application Submissions Amendments
The Food and Drug Administration is seeking public input on the content of Appendix A in its July 2018 guidance for industry, which outlines amendments to abbreviated new drug applications under the Generic Drug User Fee Amendments
Original source language: Federal Register — Food and Drug AdministrationOpen original release →